To test our hypothesis, we utilized a knock-in mouse model of AD (APPNL−F/NL−F) carrying the Swedish (NL) and Beyreuther/Iberian (F) amyloid precursor protein (APP) mutations [18, 19] that slowly develop plaque pathology starting at six months of age. This evidence concerns the gene APP and Alzheimer disease.